Get started
RocketTickers

FDA Approves Biohaven's NURTEC® ODT (rimegepant) for Prevention:

Long
Biohaven Ltd. (NYSE:BHVN)  
RocketTickers  
NYSE:BHVN   Biohaven Ltd.
Beyond Technical Analysis
1
1
beyondta
BHVN: Biohaven Pharmaceutical Holding Company Ltd.
2021-05-27 16:00:00
FDA Approves Biohaven's NURTEC® ODT (rimegepant) for Prevention: Now the First and Only Migraine Medication for both Acute and Preventive Treatment
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.